Source: The Times of India

Reliance Life Sciences: Reliance Life Sciences joins hunt for Covid vaccine

Reliance Life Sciences has become the latest company to enter the fray for developing a potential Covid-19 vaccine, which will be entering pre-clinical animal studies this month.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
K.V. Subramaniam's photo - President & CEO of Reliance Life Sciences

President & CEO

K.V. Subramaniam

CEO Approval Rating

67/100

Read more